| value |
{"aggregator_url":"https://www.sec.gov {"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000025.txt","as_of":"2026-04-03T11:12:58.166696+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000025.txt","company":"UNITED THERAPEUTICS Corp","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000025.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_fedb2cc99439eda6","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000025.txt","content_type":"text/plain","enriched_at":"2026-04-03T14:09:52.344734+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000025.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000025.txt","source_event_id":"evt_0128e91b6527","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"d33dd62ea99a9172","kind":"sec_filing","published_at":"20260402","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.9,"dates_mentioned":["2026-04-01","2026-04-02"],"entities":[{"asset_class":"equity","name":"United Therapeutics Corp","relevance":"issuer","symbol":"UTHR","type":"company"},{"asset_class":"","name":"Martine A. Rothblatt","relevance":"reporting owner","symbol":"","type":"individual"}],"event_type":"listing","information_gaps":["No specific details on the total number of shares sold in each transaction are provided.","No information on the financial implications of these transactions is included."],"key_facts":["Form 4 filed on April 2, 2026.","Martine A. Rothblatt is the Chairperson & CEO of United Therapeutics Corp.","Transactions executed under a pre-arranged 10b5-1 trading plan."],"numeric_claims":[{"label":"Total shares sold","value":"1,734,410"},{"label":"Stock options exercised","value":"9,500"}],"primary_claim":"Martine A. Rothblatt executed multiple trades involving the sale of common stock and the exercise of stock options under a pre-arranged trading plan.","relevance_score":0.8,"sentiment":"neutral","source_quality":"high","summary":"United Therapeutics Corp filed a Form 4 on April 2, 2026, disclosing stock transactions by Martine A. Rothblatt, including the exercise of stock options and sales of common stock.","topics":["SEC filing","stock transactions","executive compensation"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 UNITED THERAPEUTICS Corp \u00b7 Filed 20260402","ticker":"UTHR","tickers":["UTHR"],"title":"UTHR filed 4","url":"https://www.sec.gov/Archives/edgar/data/1082554/0001106578-26-000025.txt"}... |